Friday's top analyst upgrades and downgrades included AerCap, Barclays, Denny's, DocuSign, Intercontinental Hotels, Lennar, Luminar Technologies and Quest Diagnostics.
The MSCI indexes are rebalanced twice a year, and at the end of November, a huge rebalance is set to occur. That means some major buying in some very well-known companies.
These five high-conviction health care stock picks from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well the rest of 2020...
These five high-conviction health care picks make sense for accounts looking to gain exposure to a sector that should continue to do well the rest of 2020 and for years to come, given the aging...
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
The top analyst upgrades, downgrades and other research calls from Wednesday included Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan and Switch.
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm and Sirius XM.
Here are 10 top Ireland-based public companies with shares that are traded in the United States that may be worth putting on a watchlist.
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
The top analyst upgrades, downgrades and other research calls include Archer Daniels Midland, BlackRock, DexCom, Mallinckrodt, McDonald's, Philip Morris and Redfin.
Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.
The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove to be huge, but they are offering aggressive accounts the best entry points in...
Pandora, Hertz, Horizon Pharma, and Chicago Bridge & Iron all posted new 52-week lows on Tuesday.